超声发现的附件肿物的系统评估方法:ADNEx MR评分系统
附件病变在影像实践中常见,约20%的病变在超声评估后无法完全定性。本文综述MR成像在超声发现附件病变进一步评估中的作用,以及ADNEx MR评分系统在附件病变定性和排除卵巢癌方面的高准确性。
要点
- 超声是附件病变的一线影像检查,但约20%的病变在超声后无法完全定性。
- ADNEx MR评分系统在附件病变定性和排除卵巢癌方面已显示高度准确。
- MR成像是超声发现附件病变后进一步评估的重要方法。
核心结论
- MR成像结合ADNEx MR评分系统在超声发现附件病变的进一步评估中具有重要价值,已显示在附件病变定性和排除卵巢癌方面高度准确。
研究设计与样本
- 综述,讨论MR成像在超声发现附件病变进一步评估中的作用及ADNEx MR评分系统的效用。
诊断标准与关键数值
- ADNEx MR评分系统已显示在附件病变定性和排除卵巢癌方面高度准确。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Adnexal lesions are a common occurrence in radiology practice and imaging plays a crucial role in triaging women appropriately. Current trends toward early detection and characterization have increased the need for accurate imaging assessment of adnexal lesions prior to treatment. Ultrasound is the first-line imaging modality for assessing adnexal lesions; however, approximately 20% of lesions are incompletely characterized after ultrasound evaluation. Secondary assessment with MR imaging using the ADNEx MR Scoring System has been demonstrated as highly accurate in the characterization of adnexal lesions and in excluding ovarian cancer. This review will address the role of MR imaging in further assessment of adnexal lesions discovered on US, and the utility of the ADNEx MR Scoring System.
引用
- Sadowski EA, Robbins JB, Rockall AG, et al. A systematic approach to adnexal masses discovered on ultrasound: the ADNEx MR scoring system. Abdom Radiol (NY). 2018. PMID: 28900696. doi:10.1007/s00261-017-1272-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。